Indian Journal of Ophthalmology

BRIEF COMMUNICATION
Year
: 2009  |  Volume : 57  |  Issue : 2  |  Page : 146--148

Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents


Manish Nagpal, Kamal Nagpal, Vikram Mehta 
 Retina Foundation, Ahmedabad, India

Correspondence Address:
Manish Nagpal
Retina Foundation, Shahibaug, Ahmedabad- 380 004, Gujarat
India

Intravitreal anti-vascular endothelial growth factor (VEGF) agents have obtained acceptance as the mainstay in the management strategy of subfoveal choroidal neovascular membranes (CNVM) due to varying etiologies. Few drawbacks include need for repeated intravitreal injections, with its adjunct risks, and the lack of a predefined treatment end point, which can cause doubts and uncertainty in the mind of the patient. Furthermore, it remains a significant financial burden for the patient. Herein we report our data of three patients who were reluctant for further re-injections of anti-VEGF agents and were therefore offered surgical removal of the CNVM by submacular surgery as an alternative treatment plan.


How to cite this article:
Nagpal M, Nagpal K, Mehta V. Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents.Indian J Ophthalmol 2009;57:146-148


How to cite this URL:
Nagpal M, Nagpal K, Mehta V. Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents. Indian J Ophthalmol [serial online] 2009 [cited 2024 Mar 29 ];57:146-148
Available from: https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2009;volume=57;issue=2;spage=146;epage=148;aulast=Nagpal;type=0